Tirzepatide is suitable for individuals who are struggling with weight loss, particularly those who are obese or have health conditions related to being overweight
Some countries allow semaglutide for weight loss only if diagnosed with obesity-related conditions
A lower starting dose of 2mg partially mitigated the severity and frequency of nausea, vomiting, and diarrhea across all dose groups
Curcumin dose-dependently reversed PPA-induced deficits in social interaction, repetitive behaviors, anxiety, locomotion, learning and memory, while normalizing oxidative stress, mitochondrial dysfunction and pro-inflammatory signaling, supporting its neuroprotective efficacy in this ASD model (Yang et al., 2020)
Approved drugs are typically dispensed through registered pharmacists
10.3389/fphar.2021.611480 9